Form 4 for SRPT Sarepta Therapeutics, Inc.
Accepted 2021-11-17 00:00:00 ET · period of report 2021-11-16 · accession 0001209191-21-065315 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-11-17 | 2021-11-16 | SRPT | Mayo Stephen | Dir | A - Grant | $0.00 | +4,292 | 4,292 | New | $0 |
| D | 2021-11-17 | 2021-11-16 | SRPT | Mayo Stephen | Dir | A - Grant | $0.00 | +8,238 | 8,238 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-16 | A | A | 4,292 | $0.00 | 4,292 | D | — | — | (F1) The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. The RSUs vest in three equal annual installments beginning November 16, 2022. |
| 2 | Derivative | Stock Option (right to buy) | 2021-11-16 | A | A | 8,238 | $0.00 | 8,238 | D | $83.00 · 2022-11-16 to 2031-11-16 | 8,238 Common Stock | (F2) The option vests in three equal annual installments beginning November 16, 2022. |